bibliographic resource 1200323 [br/1200323]
https://w3id.org/oc/corpus/br/1200323

is a

• document
• article

title

• Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas

publication date

• 2005-01-01

contributor

• https://w3id.org/oc/corpus/ar/4009227
• https://w3id.org/oc/corpus/ar/4009228

format

• https://w3id.org/oc/corpus/re/567547

identifier

• https://w3id.org/oc/corpus/id/2060975
• https://w3id.org/oc/corpus/id/2060976
• https://w3id.org/oc/corpus/id/2060977

part of

• https://w3id.org/oc/corpus/br/917513